Pancreatic Cancer Research

ResearcherUniversity of HelsinkiActive in the last 2 years

Ella Kesti

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0000-0910-1842; OpenAlex author ID A5099433568. Sources: OpenAlex.

Their work

Papers
5
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2024: 1 paper · 2025: 1 paper · 2026: 3 papers

Papers 5

  1. Prognostic Value of Intratumoral Expression of Claudin 18.2 in Resected Pancreatic Cancer. Co-author DOI 10.1245/s10434-026-20191-5↗
  2. ASO Visual Abstract: Prognostic Value of Intratumoral Expression of Claudin 18.2 in Resected Pancreatic Cancer. Co-author DOI 10.1245/s10434-026-20304-0↗
  3. ASO Author Reflections: Understanding the Prognostic Role of Claudin 18.2 in Resected Pancreatic Cancer. Co-author DOI 10.1245/s10434-026-20312-0↗
  4. The prognostic significance of MMP-8 tissue Immunoexpression in pancreatic ductal adenocarcinoma after neoadjuvant therapy. Co-author DOI 10.1038/s41598-025-10538-5↗
  5. The Prognostic Significance of Collagen VI in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1097/mpa.0000000000002360↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hanna E. Seppänen · 5 shared papers, 2024–2026 · strength 1.25
  2. Caj H. Haglund · 5 shared papers, 2024–2026 · strength 1.25
  3. Malin Sund · 5 shared papers, 2024–2026 · strength 1.25
  4. Jun Yoshino · 3 shared papers, 2026 · strength 0.77
  5. Nils O. Elander · 3 shared papers, 2026 · strength 0.77
  6. Asif Halimi · 3 shared papers, 2026 · strength 0.77
  7. Oskar Franklin · 3 shared papers, 2026 · strength 0.77
  8. Hakon Blomstrand · 3 shared papers, 2026 · strength 0.77
  9. Daniel Öhlund · 3 shared papers, 2026 · strength 0.77
  10. Mirjami Kaasinen · 1 shared paper, 2025 · strength 0.25
  11. Annika Eurola · 1 shared paper, 2025 · strength 0.25
  12. Emmy Borgmästars · 1 shared paper, 2024 · strength 0.24

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.